Kodiak Sciences Inc
KOD • NASDAQ
Kodiak Sciences Inc is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Victor Perlroth, with a market cap of $2.3B.
CEOVictor Perlroth
Next Earnings
Upcoming earnings announcement for Kodiak Sciences Inc
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.85
Earnings History
Past 11 earnings reports for Kodiak Sciences Inc
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$1.16Est: -$1.05 | -10.5% | - | — |  10-Q |
| Aug 13, 2025 | Q2 2025 | -$1.03Est: -$1.03 | 0.0% | — | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$1.09Est: -$0.87 | -25.3% | - | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.84Est: -$0.86 | +2.3% | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.84Est: -$0.90 | +6.7% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.86Est: -$1.19 | +27.7% | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.82Est: -$1.07 | +23.4% | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$1.13Est: -$0.77 | -46.8% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.95Est: -$1.21 | +21.5% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$1.53Est: -$1.31 | -16.8% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$1.35Est: -$1.33 | -1.5% | - | — | 10-Q |